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Abstract

CYP17A1 is a key steroidogenic enzyme known to conduct several distinct chemical transformations on multiple
substrates. In its hydroxylase activity, this enzyme adds a hydroxyl group at the 17α position of both
pregnenolone and progesterone at approximately equal rates. However, the subsequent 17,20 carbon–carbon
scission reaction displays variable substrate specificity in the numerous CYP17A1 isozymes operating in
vertebrates, manifesting as different Kd and kcat values when presented with 17α-hydroxypregnenlone (OHPREG)
versus 17α-hydroxyprogesterone (OHPROG). Here we show that the identity of the residue at position 202 in
human CYP17A1, thought to form a hydrogen bond with the A-ring alcohol substituent on the pregnenenucleus, is a key driver of this enzyme’s native preference for OHPREG. Replacement of asparagine 202 with
serine completely reverses the preference of CYP17A1, more than doubling the rate of turnover of the OHPROG
to androstenedione reaction and substantially decreasing the rate of formation of dehydroepiandrosterone
from OHPREG. In a series of resonance Raman experiments, it was observed that, in contrast with the case for
the wild-type protein, in the mutant the 17α alcohol of OHPROG tends to form a H-bond with the proximal
rather than terminal oxygen of the oxy–ferrous complex. When OHPREG was a substrate, the mutant enzyme
was found to have a H-bonding interaction with the proximal oxygen that is substantially weaker than that of
the wild type. These results demonstrate that a single-point mutation in the active site pocket of CYP17A1, even
when far from the heme, has profound effects on steroidogenic selectivity in androgen biosynthesis.
P450 CYP17A1 (CYP17A1) is a steroidogenic enzyme of critical importance in the pathway leading to the
formation of androgens (Figure 1). Primarily localized in tissues of the adrenal gland and sex organs, the
multifunctional CYP17A1 catalyzes the 17α hydroxylation of pregnenolone and progesterone as well as the
subsequent 17,20 carbon–carbon bond scission or “C–C lyase” that gives rise to dehydroepiandrosterone (DHEA)
and androstenedione (AD).(1, 2) Though subsequent biological transformations are required to generate the
potent androgen receptor agonists testosterone and dihydrotestosterone, the upstream lyase activity of
CYP17A1 is the first committed step in their production. The importance of these androgens in the proliferation
of prostate cancer, coupled with the disappointing performance of 5α-reductase inhibitors, has created intense
interest in this enzyme, most notably resulting in the development and approval of the inhibitor, abiraterone
acetate. A groundbreaking 2012 publication described the crystal structure of CYP17A1,(3) yet much regarding
the nature of key substrate–protein interactions that drive the selectivity of CYP17A1 remains unknown.

Figure 1. Structures of substrates and products of CYP17A1.
Human CYP17A1 is known to exhibit a strong preference for hydroxypregnenolone (OHPREG) over
hydroxyprogesterone (OHPROG) when catalyzing carbon–carbon scission chemistry, despite its ability to
hydroxylate pregnenolone and progesterone at roughly equivalent rates.(4, 5) This roughly 50-fold difference in
terms of kcat/Km favoring OHPREG drives steroidogenic flux in humans predominantly through the OHPREG to
DHEA pathway. However, preference for the OHPREG substrate is not conserved across CYP17 isozymes
operating in the vertebrata subphylum. Whereas some isozymes have the same substrate preference as human

CYP17A1, others have no substrate preference and still others more favorably catalyze the OHPROG to AD
reaction.(6, 7) Although detailed studies of the activity of CYP17 enzymes across a range of species are still a
work in progress, the Usanov laboratory has carefully evaluated the activities of various vertebrate CYP17
enzymes under identical conditions and classified their activities as favoring OHPREG or OHPROG or as having no
preference(6) (Table 1). Insight into the origin of these discrete substrate preferences was finally provided in
seminal work by the Scott laboratory in which the crystal structure of truncated human CYP17A1 was
determined first in the presence of its inhibitor, abiraterone, as well as subsequent structures of the A105L
CYP17A1 mutant in the presence of all four native substrates.(3, 8) In all cases, the pregnene- nucleus is
perpendicular to the heme with its D-ring juxtaposed against the iron atom and the β-face of the steroid
directed toward the I-helix. Importantly, the C-3 substituent (−OH or ═O) is generally positioned within
hydrogen bonding distance of asparagine 202, which projects its side chain from the F-helix into the active site
cavity.
Table 1. Sequence Alignment of Various CYP17 Enzymes with Associated Turnover Numbers with OHPREG or
OHPROG as a Substratea
species
Homo sapiens
Bos taurus
Bos bison
Felis catus
Cavia porcellus
Equus caballus
Rattus norvegicus
Xenopus laevis
a

sequence
LNVIQNY-N-EGIIDNL
LKAIQNV-N-DGILEV
LKAIQNV-N-DGILEV
LKIIQNY-N-EGILKTL
LVTIRRF-T-TGFVNS
LETMQNY-H-KGILE
LTAIKTF-T-EGIVDA
FEEMLAY-S-KGIVDT

OHPREG
1.4
4.6
1.7
0.3
NMb
10.5
0.8
0.09

OHPROG
NMb
NMb
NMb
NMb
1.7
27.1
2.2
0.14

Product formation is expressed in units of nanomoles per minute per nanomole of P450 as documented by Usanov et al.(6)
Not measured.

b

Emerging evidence suggests that even small changes in the hydrogen bonding patterns at position 202, which is
remote from the heme active center, can substantially impact the position of substrates near the active iron–
oxygen intermediate responsible for catalysis in a manner that may either facilitate or hinder product
formation.(9) The choice between a keto or alcohol group at the C-3 position directs the 17α-OH group of the
substrate to form a hydrogen bond (H-bond) to either the proximal (OHPREG) or distal (OHPROG) oxygen of the
oxy complex that persists following the subsequent one-electron reduction that forms the peroxo–ferric
intermediate.(10) This is an essential distinction owing to the mechanism employed by CYP17A1 in the
formation of androgens. Among the steroidogenic P450s, CYP17A1 is believed to be unique in that the C–C lyase
chemistry can be initiated not by the traditional ferryl–oxene species but by a nucleophilic attack on the C-20
carbonyl by a reactive peroxo–ferric intermediate.(5, 10-13) The resultant peroxo hemiketal may then
decompose to the androgen product and acetic acid. Importantly, this mechanism is dependent upon
unencumbered access to C-20 by the distal oxygen of the peroxoanion.
To determine the relevance of N202 in substrate specificity, sequence alignments were performed (Table 1), and
the residue identity at position 202 was compared to substrate preference, in terms of the product formation
rates of the various vertebrate CYP17 enzymes published previously by the Usanov group.(6) In the case of
enzymes that favor OHPREG as a substrate, an asparagine residue is generally conserved. However, in enzymes
with an alternate preference, a serine or threonine residue generally occupies this position. On the basis of side
chain torsion or mobility in proteins containing N202, this residue can potentially donate a H-bond to the keto
group of OHPROG or accept a H-bond from the alcohol C-3 substituent on OHPREG substrates, respectively

(Figure 2A,B).(8) We hypothesize that the alcohol presented by serine and threonine residues would form a
favorable interaction with the keto fragment presented by OHPROG (Figure 2D). Expanding on results from the
Usanov group in which this subtle alteration in side chain identity substantially impacted product formation
rates, we postulated that this alcohol would fail to form the H-bonding interaction with OHPREG or the requisite
geometry to form such an interaction would orient the substrate unfavorably for catalysis (Figure 2C).

Figure 2. Schematic of hydrogen bonding interactions between substrates and asparagine or serine 202.
To explore the role of the residue at position 202, which is located far from the heme center, we generated the
N202S mutant in human CYP17A1 with the thought that this would reverse the substrate specificity of this
isozyme. We reasoned that the choice of serine versus threonine or histidine was least likely to result in a steric
clash owing to the diminished side chain bulk relative to other residues observed in other CYP17 isozymes. We
further hypothesized that such a mutation would alter the position of the substrate in the active site. Among
other alterations in individual catalytic steps, loss of the H-bond accepting character of the asparagine residue
that directs the 17α alcohol to hydrogen bond with the proximal oxygen in the oxy– and peroxo–ferric forms
could now explicitly favor OHPROG as a substrate in the C–C lyase reaction. The resultant mutant of CYP17A1
was expressed in high yield and purified to electrophoretic homogeneity prior to incorporation into Nanodiscs.
The Nanodisc system consists of CYP17A1 embedded in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) lipid bilayer encircled by a solubilizing amphipathic scaffold protein.(14-17) Use of this system permits
interrogation of the full-length and membrane-bound CYP17A1 protein under essentially native but controlled
conditions and has found wide use in the study of this and many other proteins.(18)

Experimental Procedures
Expression, Purification, and Nanodisc Incorporation of N202S CYP17A1

The N202S mutant was generated using a codon-optimized full-length human wild-type CYP17A1 synthetic gene
(DNA 2.0) in the pCWori plasmid. Mutagenesis was performed using iProof polymerase with primers obtained
from Integrated DNA Technologies. Forward primers were 5′TGAATGTGATCCAGAATTACAGTGAGGGCATCATCGACAAT-3′. Reverse primers were 5′ATTGTCGATGATGCCCTCACTGTAATTCTGGATCACATTCA-3′. Sequencing was performed by ACGT Inc. Expression,
purification, and Nanodisc incorporation for both wild-type and N202S CYP17A1 were performed as previously
described.(9, 19)

Substrate Binding Titrations

Spectral dissociation constants were determined by the sequential addition of substrate dissolved in methanol
to a cuvette containing 1.5 μM CYP17A1 in 100 mM potassium phosphate (pH 7.4) and 50 mM NaCl. Electronic
absorption spectra were recorded from 350 to 800 nm in a Cary 300 spectrophotometer at 25 °C. Spectral
dissociation constants were estimated by plotting the change in the peak to trough A390 – A420 difference spectra
versus substrate concentration and fitting the resultant binding isotherm to the quadratic tight binding
equation.(20) For each substrate/enzyme pair, titrations were performed in triplicate, and the percent high spin
was calculated at each substrate concentration using a peak to trough extinction coefficient in the difference
spectra (ε390–420) of 100 mM–1 cm–1.(21) The error is reported as ±1 standard deviation.

Product Formation

Rat cytochrome P450 oxidoreductase and cytochrome b5 were expressed and purified as described
previously.(22, 23) These proteins were inserted into Nanodiscs containing wild-type or N202S CYP17A1 as
described by Grinkova et al.(24) Product formation rates were determined under saturating concentrations (40
μM) of OHPREG or OHPROG in 100 mM potassium phosphate buffer (pH 7.4) and 50 mM NaCl. Mixtures
containing 0.2 nmol of wild-type or N202S CYP17A1 Nanodiscs, 0.8 nmol of cytochrome b5, and 0.8 nmol of
cytochrome P450 oxidoreductase in 1.0 mL of buffer were warmed to 37 °C, and the reaction was initiated by
addition of 400 nmol of NADPH. After 10 min, reactions were quenched by addition of 50 μL of 8.9 N H2SO4, and
mixtures were flash-frozen in liquid N2 and stored at −80 °C.
Methods for extraction and quantitation of the products have been described in detail elsewhere.(5, 13,
25) Briefly, products were extracted with 1.5 mL of dichloromethane after addition of a progesterone internal
standard and dried under a stream of N2. Products of the OHPROG to AD reaction were analyzed by reversedphase high-performance liquid chromatography after reconstitution in 100 μL of methanol. Separation was
achieved using an ACE3 C18 column and a linear gradient beginning with a 5:5:90 methanol:acetonitrile:water
ratio and ending with a 45:45:10 methanol:acetonitrile:water ratio. Mobile phases were supplemented with
0.2% formic acid, and the product was observed optically at 240 nm. The DHEA product was analyzed on a FIDequipped gas chromatograph fitted with a 30 m DB-17 capillary column as described previously.(13)

Sample Preparation for Resonance Raman (rR) Spectroscopy

Ferric rR samples contained 150 μM N202S CYP17A1 Nanodiscs in 100 mM potassium phosphate buffer (pH 7.4)
with 15% (v/v) glycerol and 450 μM OHPREG or OHPROG. Oxy–ferrous samples contained 150 μM N202S
CYP17A1 Nanodiscs in 100 mM potassium phosphate (pH 7.4), 250 mM NaCl, and 30% (v/v) distilled glycerol.
OHPREG, OHPROG, PREG, or PROG was added to a final concentration of 450 μM. Samples were deoxygenated
under argon and reduced with a 1.5-fold molar excess of sodium dithionite in the presence of 3.8 μM methyl
viologen. Each sample was then chilled to −15 °C in a dry ice/ethanol bath and oxygenated by being bubbled
with 16O2 or 18O2 for 5 s. Samples were immediately flash-frozen in liquid N2 and stored at 77 K.

rR Sample Measurements

Resonance Raman spectra of the oxy complexes were recorded using a Spex 1269 spectrometer attached to a
Spec-10 liquid nitrogen-cooled detector with a 2048-pixel resolution (Princeton Instruments, Princeton, NJ). The
emission line at 413.1 nm from a Kr+ laser was focused by a cylindrical lens on the sample that was immersed in
liquid nitrogen during data collection. The rR data were measured using this 413.1 nm line from the Kr+ laser
(Coherent Innova Sabre Ion Laser) and collected using back scattering (180°) geometry with the laser beam
being focused by a cylindrical lens to form a line image on the frozen sample contained in 5 mm outside
diameter NMR tubes (WG-5 ECONOMY, Wilmad). The NMR tubes were positioned into a homemade doublewalled quartz low-temperature cell filled with liquid nitrogen. The sample tubes were spun to avoid local

heating. The laser power was adjusted to ≤1 mW. All measurements were performed at 77 K, and the total
collection time was ∼3 h in the high-frequency region and ∼4 h in the low-frequency region. The slit width was
set at 150 μm, and a 1200 g/mm grating was used. Spectra were calibrated with fenchone (Sigma-Aldrich,
Milwaukee, WI) and processed with Grams/32 AI software (Galactic Industries, Salem, NH).

Results and Discussion
Substrate Binding and Product Formation of N202S CYP17A1

In a first set of experiments, we characterized the stability and substrate binding properties of N202S CYP17A1
using electronic absorption spectroscopy. Once incorporated into Nanodiscs, the mutant protein is exceptionally
stable, showing nearly 100% P450 in the ferrous:CO form. Soret maxima were identical to those of the wild-type
enzyme: 417 nm for the ferric substrate free form, 393 nm in the ferric substrate-bound state, and 408 nm when
the protein is reduced to the ferrous state with sodium dithionite. Spectral dissociation constant (Ks) values for
wild-type and N202S CYP17A1 were obtained by sequential additions to samples of the four native substrates
from methanolic stocks while the change in spin state was being monitored. In the case of the wild-type
enzyme, Ks values for both PREG and PROG were roughly equivalent at 66 ± 11 and 41 ± 2.5 nM, respectively.
Values for OHPREG and OHPROG were higher for the lyase substrates, and notable differences in affinity were
distinguishable for the 17-OH derivatives. For OHPREG, the Ks was measured to be 170 ± 15 nM, and for
OHPROG, it was 550 ± 17 nM (Figure 3).

Figure 3. Substrate binding isotherms of wild-type and N202S CYP17A1. Solid lines denote data for the wild-type
enzyme and dashed lines data for N202S.
When binding of hydroxylase substrates to the N202S enzyme was monitored, the results were significantly
different from those observed for wild-type CYP17A1. Although PROG (Figure 3B) was largely unaffected by this
mutation (Ks = 16 ± 4.1 nM), binding of PREG was significantly impaired with a calculated Ks of 380 ± 57 nM
(Figure 3A). Notably, the substrate preference of the lyase substrates was reversed for the mutant protein
relative to that of the wild type. In the case of OHPREG, the Ks increased by nearly an order of magnitude to
1500 ± 88 nM (Figure 3C). On the other hand, OHPROG bound substantially more tightly to N202S than to the
wild type with a Ks of 53 ± 12 nM (Figure 3D). These results support a key role for an interaction between the
substrate C-3 substituent and the residue present at position 202. Because the only other polar groups on the
substrate (the 17α-OH and C-20 carbonyl) are positioned near the heme and are not seen to form contacts with
protein side chains in any available crystal structures,(8) specific favorable interactions between residue 202 and
A-ring keto or alcohol groups are likely essential determinants in dictating binding affinity.
Another important probe of interaction of the ligand with the enzyme is the extent to which the P450 is
converted to the “high-spin” state as substrate binding displaces water as the sixth ligand of the heme
iron.(21) In the case of the wild-type enzyme, binding of PREG resulted in essentially complete low- to high-spin

conversion, while PROG stimulated only a 90% transition to the high-spin form. In contrast, for this set of
substrates, experiments with the N202S mutant exhibited behavior that was the opposite of that of the wild
type: PREG binding resulted in a 92% shift to the high-spin state, while PROG binding saw a complete transition
(panels A and B of Figure 3, respectively). In the case of lyase substrates, the wild-type enzyme again exhibited a
more complete spin shift for substrates presenting a C-3 alcohol. For OHPREG and OHPROG, conversion to the
high-spin state was 86% and 79%, respectively. Again, for the N202S mutant, the effects of substrates were
reversed versus those of the wild type: OHPREG induced an 83% shift to the high-spin state, while OHPROG now
caused an 88% conversion (panels C and D of Figure 3, respectively). Expulsion of water as a ligand to the heme
iron is highly sensitive to the presence and orientation of the substrate in the distal active site pocket. Therefore,
these results offer evidence that subtle differences in interactions between A-ring substituents and the residue
at position 202 are reliably translated as differences in positioning of the D-ring near the heme.
Next, we determined the role of N202 mutations in the function of CYP17A1. Steady state turnover rates for
both wild-type and mutant enzymes were measured in parallel using saturating concentrations of OHPREG or
OHPROG in the presence of a 4-fold molar excess of cytochrome b5 and cytochrome P450 oxidoreductase
relative to CYP17A1. Interestingly, we found that substitution of N202 with a serine residue not only reversed
binding affinity and spin state conversion but also had a significant impact on the product formation rates for
the lyase reaction (Figure 4). As expected, formation of DHEA by the N202S mutant was impaired (0.12 min–1)
relative to that by the wild type (0.41 min–1). However, the product formation rate of AD more than doubled for
the mutant protein relative to that for the wild type, increasing from 0.20 to 0.49 min–1. These differences in the
rate of enzyme turnover are unrelated to the changes in binding affinity, as all experiments were performed in
the presence of saturating substrate concentrations. Rather, differences in product formation rates in the
mutant protein are likely reflective of the substrate adopting an orientation more favorable for catalysis in the
case of OHPROG, or less favorable in the case of OHPREG as revealed by rR spectroscopy.

Figure 4. Steady state turnover of WT and N202S CYP17A1. Error bars represent ±1 standard deviation.

Resonance Raman Spectroscopy of the Oxy–Ferrous Form of N202S CYP17A1

In a previous study, we successfully documented a unique pattern of hydrogen bonding in which the 17-OH of
the substrate forms a direct H-bond to the distal oxygen of the oxy–ferrous complex when OHPROG is a
substrate, and the proximal oxygen atom when OHPREG is a substrate.(9) This hydrogen bonding pattern was
found to persist in the subsequent peroxo–ferric species,(10)leaving the distal oxygen free to initiate a
nucleophilic attack on the substrate C-20 carbonyl when OHPREG was a substrate. To explore the subtle changes
in substrate orientation caused by the N202S mutation, we used rR spectroscopy to examine the nature of Hbonding interactions between the substrate 17-OH and iron-bound dioxygen. The rR spectra of ND:CYP17A1
N202S samples containing PROG and PREG substrates are identical and exhibit clear ν(Fe–O) and ν(O–O)
stretching modes at 535 and 1139 cm–1, respectively (Figure 5, traces A and B). The 16O2 – 18O2 isotopic shifts are

as expected,(26-28) i.e., 29 and 66 cm–1 for ν(Fe–O) and ν(O–O) modes, respectively. It is noted that the spectral
patterns of the PROG- and PREG-bound mutant are almost identical to those of wild-type samples with
corresponding substrates; i.e., the differences in frequencies are <1 cm–1 (Table 2). Differences in the orientation
of these two substrates within the mutant active site do not substantially impact the Fe–O–O fragment because
of the lack of a substrate-associated polar OH group within the immediate vicinity of the Fe–O–O fragment.

Figure 5. 16O2 – 18O2 difference traces of the (A) PROG-, (B) PREG-, (C) OHPROG-, and (D) OHPREG-bound N202S
mutant in the low-frequency (left) and high-frequency (right) regions.
Table 2. Comparison of the ν(Fe–O) and ν(O–O) Modes for Wild-Type and N202S CYP17A1
PREG (WT)
OHPREG (WT)
Δwavenumber
PROG (WT)
OHPROG (WT)
Δwavenumber
PREG (N202S)
OHPREG (N202S)
Δwavenumber
PROG (N202S)
OHPROG (N202S)
Δwavenumber

ν(Fe–O) (cm–1)
535
526
–9
536
542
+6
535
530
–5
535
530
–5

ν(O–O) (cm–1)
1140
1135
–5
1140
1131
–9
1139
1133
–6
1139
1131
–8

ref
9
9
9
9
9
9
–
–
–
–
–
–

As shown in Figure 5, high-quality rR spectra were also obtained for the dioxygen adducts of the samples bearing
the hydroxylated substrates, OHPROG and OHPREG. The OHPROG sample exhibits ν(O–O) and ν(Fe–O) modes at
1131 and 530 cm–1, respectively, with expected 16O2 – 18O2 isotopic shifts (65 and 29 cm–1, respectively). A similar
spectral pattern is observed for the OHPREG-bound sample; the ν(O–O) stretching mode is observed at 1133
cm–1 (65 cm–1 downshift upon 18O2 substitution), and the ν(Fe–O) mode is observed at 530 cm–1, where
the 16O2 – 18O2 difference is 29 cm–1.

Referring to Figure 5 and Table 2, which reports rR spectral data for the O2adducts of the wild type and N202S
mutant, we emphasize that no significant changes in the internal modes of the Fe–O–O fragment were seen for
the nonpolar PROG and PREG substrates; e.g., the ν(Fe–O) modes are seen at ∼535 cm–1, and the ν(O–O) modes
are observed at ∼1140 cm–1 for the WT and N202 mutant containing PROG and PREG substrates. On the other
hand, the spectra acquired for the N202S samples containing OHPROG and OHPREG are significantly different
from the data acquired for the WT protein, with the changes mostly localized on the ν(Fe–O) vibrations. Thus, all
four samples containing hydroxylated substrates, including WT and N202S mutant proteins, exhibit a ν(O–O)
mode shifted by 5–9 cm–1 [Δwavenumber (Table 2)] from its position for the nonhydroxylated substrates,
behavior that is consistent with the introduction of a new H-bonding residue in the vicinity of the Fe–O–O
fragment.
Most importantly, the variations of the ν(Fe–O) modes in response to the two different hydroxylated substrates,
OHPROG and OHPREG, are revealing. In a previous work(9) that focused on the WT protein, convincing
arguments, supported by experimental(29-35) and computational(36) studies, were made to suggest that the C–
OH group of OHPROG interacts with the terminal oxygen (Ot) of the Fe–Op–Ot fragment, causing a significant
shift of the ν(Fe–O) mode to a higher frequency (542 cm–1), relative to the values observed for the nonpolar
substrates. Conversely, the C–OH group of OHPREG interacts with the proximal (Op) oxygen atom of the Fe–Op–
Ot fragment, causing a shift of the ν(Fe–O) to a substantially lower frequency (526 cm–1).
Important for this work is the fact that the apparent substrate repositioning caused by the N202S mutation
drastically alters the resultant interactions of the substrate-associated OH groups with the Op and Ot atoms of
the Fe–Op–Otfragment, as is evident from the observed shifts of the ν(Fe–O) modes. The ν(Fe–O) mode in the
mutant sample containing OHPROG is observed at a frequency 12 cm–1 lower than that of the ν(Fe–O) mode in
the OHPROG-bound WT sample (530 cm–1 in N202S vs 542 cm–1 in the WT). Conversely, the ν(Fe–O) mode of the
OHPREG sample is 4 cm–1 higher in the mutant than it is in the WT sample (530 cm–1 in N202S vs 526 cm–1 in the
WT) (Table 2 and Figure 6).

Figure 6. Alteration of the pattern of bonding of hydrogen of wild-type and N202S CYP17A1 to the heme-bound
dioxygen. The Fe–O wavenumber is indicated on the abscissa.
While it is possible that the alteration of ν(Fe–O) stretching frequencies in the P450 samples with hydroxylated
substrates might arise from electrostatic or structural changes on the proximal side of the heme pocket, such
changes are usually reflected in changes in Fe–S bond strength. For instance, it was shown previously(37) that
the alteration of polar interaction among anionic reductase, putidaredoxin, and the positively charged proximal
side of the CYP101 led to a 3 cm–1 upshift of the ν(Fe–S) mode. Enhanced electron donation through a π-bonding
interaction between a sulfur p orbital and the Fe dπ orbital resulted in significant strengthening of the Fe–S
bond. However, measurements of N202S samples containing ferric OHPROG or OHPREG substrate using UV
excitation revealed that the ν(Fe–S) stretching mode is observed at 347 cm–1 in the spectra of both samples
(data not shown). This observation is consistent with the lack of a substrate effect on Fe–S bond strength in the

WT protein, where the ν(Fe–S) stretching mode was also observed at 347 cm–1 in the presence of each of the
four substrates.(38) This lack of changes in the ν(Fe–S) mode among all studied samples effectively argues that
the proximal factors are negligible and that the observed changes in ν(Fe–O) modes arise only from the distal
side effects, i.e., hydrogen bonding interactions with the Fe–O–O fragment.
One reasonable interpretation of these shifts is that the downshift of the ν(Fe–O) mode in the mutant sample
with OHPROG reflects a shift in the H-bonding interaction of the C–OH group from the Ot atom to the Op atom of
the Fe–O–O fragment, though not to such a degree as was seen for the WT case with the OHPREG
substrate.(9) Such a change in directionality of the H-bonding interaction is a clear indication that the positions
of the OHPREG and OHPROG lyase substrates are mediated, at least in part, by interactions between the
substrate C-3 substituent and the residue at position 202 in human CYP17A1.
The discrete positioning of the substrate in the active site of a cytochrome P450 can have a profound impact on
the catalytic efficiency of the enzyme. Because of the complexity of the P450 reaction cycle, there can be
alterations in multiple steps. Interaction of the substrate with the distal water in the ferric low-spin complex can
result in a significant modulation of the spin-state equilibrium with a corresponding impact on the ferric–ferrous
redox potential and electron transfer rates. Structural changes that allow more or less water into the enzyme
active site, with a resultant change in active site polarity, can also modulate the degree of coupling of pyridine
nucleotide reducing equivalents to the product. Overall positioning relative to the heme-bound “active oxygen”,
either a Compound I or peroxoanion, is of obvious importance to product formation. In all likelihood, multiple
structural and dynamic factors may be involved.
It is interesting, however, to link the observed changes in hydrogen bonding between the 17-OH groups of these
steroids with results suggesting the involvement of the peroxoanion intermediate in the initiation of the carbon–
carbon bond scission event. In previous work,(13) we utilized kinetic solvent isotope effects (KSIEs) to document
the nature of a peroxoanion intermediate as a critical branching point in lyase catalysis. Observation of an
unusual inverse KSIE suggested a reactivity of the peroxoanion before protonation leading to O–O bond scission
and formation of the Compound I metal–oxo intermediate that is active in normal hydroxylation chemistry.
Rather, nucleophilic attack of the distal oxygen of the peroxo anion on the C-20 carbonyl would yield a
hemiketal intermediate that was trapped at low temperatures.(10) Previous publications also used resonance
Raman spectroscopy to monitor the differential hydrogen bonding patterns between the 17-OH group of
OHPREG and OHPROG and the proximal and distal oxygen atoms in the ferrous dioxygen intermediate and
showed that these patterns persist as the peroxoanion is formed.(9, 10) The results presented here document
how substrate repositioning due to interactions at the A-ring can modulate the bonding of hydrogen to the
heme-bound oxy–ferrous complex and thus contribute to a mechanistic understanding.
If the mechanism of lyase activity involves the peroxoanion as we and others have suggested,(10, 11, 13) then
the observed increase in the level of bonding of hydrogen to Op would be expected to free the terminal oxygen
Ot to initiate a nucleophilic attack on the C-20 carbonyl, thus potentially increasing the lyase activity of the
N202S mutant of OHPROG as compared to that of the wild type.
Such an interpretation is supported by the product formation data reported herein, which show a 2-fold higher
level of production of AD from OHPROG by the N202S mutant than by the wild type. On the other hand, the
upshift of the ν(Fe–O) mode in the mutant sample containing OHPREG reflects a weakening of the bonding of
hydrogen to Op, relative to that of the WT protein (Figure 6). This interpretation is also supported by the product
formation studies, which show that the level of production of DHEA from OHPREG in the mutant is
approximately 25% of that observed for the WT sample.

From another perspective, it is noted that the rR spectral patterns of dioxygen adducts of the mutant in the
presence of both hydroxylated substrates are consistent with virtually identical H-bonding interactions with the
Fe–Op–Otfragment, both being mildly poised for peroxo attack on C-20,(9, 10) yet the product formation rate of
the OHPROG sample (0.49 min–1) is 4 times higher than that of the OHPREG-bound sample (0.12 min–1). This
observation leads to the conclusion that, while H-bonding interactions can play a significant role in controlling
activity, when they are apparently equivalent, other factors certainly influence the overall enzymatic activity.
In addition to other confounding complexities in the P450 reaction cycle mentioned previously, we also note
that the discrepancy between the magnitude of the change in ν(Fe–O) modes and product formation rates in WT
versus N202S may also be attributable to the absence of reductase and cytochrome b5 in our rR samples. As
noted, the Fe–O–O fragment is especially susceptible to the strength and orientation of distal pocket H-bonding
interactions.(36) There is ample precedent to suggest that binding of the redox partner to an oxy adduct of a
cytochrome P450 (CYP101 and CYP11A1) can alter H-bonding interactions with the Fe–O–O fragments.(39,
40) These considerations suggest that further, more elaborate, and technically demanding rR spectroscopic
studies are required to fully clarify the nature of H-bonding interactions with the Fe–O–O fragments of these
enzymes in the presence of redox partners.
In conclusion, these spectroscopic and functional studies provide convincing evidence that the N202 residue of
CYP17A1 plays a critical role in defining not only the affinity for either OHPREG or OHPROG but also the
orientation of these hydroxylated substrates in the active site. These results demonstrate that minute changes
resulting from a single-point mutation in the hydrogen bonding environment in the active site cavity, even when
distant from the heme catalytic center, are capable of modulating this enzyme’s lyase activity. Notably, these
results highlight the ability of this single residue to fine-tune the activity of CYP17A1 to adjust to the unique
steroidogenic needs of various species.
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